Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

USANA Health Sciences, Inc. (USJ.F)

Compare
22.60
0.00
(0.00%)
At close: April 4 at 9:39:52 PM GMT+2
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
854,503
854,503
921,010
998,601
1,186,464
Cost of Revenue
161,212
161,212
176,693
193,890
217,898
Gross Profit
693,291
693,291
744,317
804,711
968,566
Operating Expense
626,967
626,967
651,246
697,097
798,374
Operating Income
66,324
66,324
93,071
107,614
170,192
Net Non Operating Interest Income Expense
11,038
11,038
9,375
3,597
2,458
Other Income Expense
-1,011
-1,011
7
-2,590
-2,008
Pretax Income
76,351
76,351
102,453
108,621
170,642
Tax Provision
34,291
34,291
38,665
39,271
54,137
Net Income Common Stockholders
42,060
42,060
63,788
69,350
116,505
Diluted NI Available to Com Stockholders
42,060
42,060
63,788
69,350
116,505
Basic EPS
2.84
2.21
3.33
3.61
5.99
Diluted EPS
2.83
2.19
3.30
3.59
5.73
Basic Average Shares
19,118.75
19,064
19,130
19,206
19,393
Diluted Average Shares
19,198.75
19,162
19,345
19,310
20,343
Total Operating Income as Reported
66,324
66,324
93,071
107,614
170,192
Total Expenses
788,179
788,179
827,939
890,987
1,016,272
Net Income from Continuing & Discontinued Operation
42,060
42,060
63,788
69,350
116,505
Normalized Income
42,060
42,060
63,788
69,350
116,505
Interest Income
11,319
11,319
9,637
3,789
2,515
Interest Expense
281
281
262
192
57
Net Interest Income
11,038
11,038
9,375
3,597
2,458
EBIT
76,632
76,632
102,715
108,813
170,699
EBITDA
98,861
98,861
123,110
130,223
192,892
Reconciled Cost of Revenue
161,212
161,212
176,693
193,890
217,898
Reconciled Depreciation
22,229
22,229
20,395
21,410
22,193
Net Income from Continuing Operation Net Minority Interest
42,060
42,060
63,788
69,350
116,505
Normalized EBITDA
98,861
98,861
123,110
130,223
192,892
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 11/5/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade